Figure 1.

Schematic of the workflow involved in (A) creating transgenic mice using pronuclear microinjection into fertilized eggs [20] or (B) viral vector-mediated expression of viral entry receptors to develop mouse models susceptible to human viral infections. Created using BioRender.